Safe harbours for the integration of new DNA in the human genome
暂无分享,去创建一个
Michel Sadelain | Frederic D. Bushman | F. Bushman | M. Sadelain | E. Papapetrou | Eirini P. Papapetrou
[1] M. R. Delgado Alvira,et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[2] Eric D. Adler,et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.
[3] Frederic D. Bushman,et al. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. , 2010, Blood.
[4] Christof von Kalle,et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. , 2009, The Journal of clinical investigation.
[5] Michel Sadelain,et al. Hematopoietic stem cell engineering at a crossroads. , 2012, Blood.
[6] D. Cox,et al. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15 , 1984, Nature.
[7] Erin L. Doyle,et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.
[8] J. Maloof. Recent advances in regulation of flowering , 2010, F1000 biology reports.
[9] Linzhao Cheng,et al. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. , 2011, Blood.
[10] E. Henckaerts,et al. Adeno-associated virus: a key to the human genome? , 2010, Future virology.
[11] C. Mackay,et al. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. , 1997, The American journal of pathology.
[12] R. Samulski,et al. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. , 2004, Annual review of genetics.
[13] Frédéric Pâques,et al. Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy. , 2007, Current gene therapy.
[14] Kathryn L. Parsley,et al. Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction , 2011, Science Translational Medicine.
[15] Xiangdong Fang,et al. Locus control regions. , 2002, Blood.
[16] Shawn M. Burgess,et al. Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.
[17] S. Rivella,et al. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. , 1998, Seminars in hematology.
[18] Paul Shinn,et al. Integration Targeting by Avian Sarcoma-Leukosis Virus and Human Immunodeficiency Virus in the Chicken Genome , 2005, Journal of Virology.
[19] Manfred Schmidt,et al. Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.
[20] R. Pedersen,et al. Robust, Persistent Transgene Expression in Human Embryonic Stem Cells Is Achieved with AAVS1‐Targeted Integration , 2008, Stem cells.
[21] D. W. Emery. The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors. , 2011, Human gene therapy.
[22] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[23] Lei Zhang,et al. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. , 2010, Genome research.
[24] Cameron S. Osborne,et al. LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.
[25] M. Jasin,et al. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis , 2010, Nature Reviews Molecular Cell Biology.
[26] Christine Kinnon,et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.
[27] R. Jaenisch,et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.
[28] C. Ramachandra,et al. Efficient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors , 2011, Nucleic acids research.
[29] D. Haussler,et al. Ultraconserved Elements in the Human Genome , 2004, Science.
[30] Mario R. Capecchi,et al. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century , 2005, Nature Reviews Genetics.
[31] Zeger Debyser,et al. LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[32] G. Keller,et al. Identification and targeting of the ROSA26 locus in human embryonic stem cells , 2007, Nature Biotechnology.
[33] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[34] Luca Biasco,et al. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. , 2007, The Journal of clinical investigation.
[35] Takeshi Suzuki,et al. Genome-Based Identification of Cancer Genes by Proviral Tagging in Mouse Retrovirus-Induced T-Cell Lymphomas , 2003, Journal of Virology.
[36] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[37] Michel Sadelain,et al. Occurrence of leukaemia following gene therapy of X-linked SCID , 2003, Nature Reviews Cancer.
[38] L A Herzenberg,et al. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Kotin,et al. Characterization of a preferred site on human chromosome 19q for integration of adeno‐associated virus DNA by non‐homologous recombination. , 1992, The EMBO journal.
[40] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[41] A. Zander,et al. Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. , 2003, Blood.
[42] Luca Biasco,et al. Comprehensive genomic access to vector integration in clinical gene therapy , 2009, Nature Medicine.
[43] Y. Isaka,et al. Perspectives for gene therapy in renal diseases. , 2004, Internal medicine.
[44] Dana Carroll,et al. Gene targeting using zinc finger nucleases , 2005, Nature Biotechnology.
[45] Shoshannah L. Roth,et al. A method to sequence and quantify DNA integration for monitoring outcome in gene therapy , 2011, Nucleic acids research.
[46] T. Kanda,et al. Identification of an Insulator in AAVS1, a Preferred Region for Integration of Adeno-Associated Virus DNA , 2003, Journal of Virology.
[47] M. Jasin,et al. Genetic manipulation of genomes with rare-cutting endonucleases. , 1996, Trends in genetics : TIG.
[48] Philip R. Johnson,et al. Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues , 2005, Journal of Virology.
[49] Takeshi Suzuki,et al. RTCGD: retroviral tagged cancer gene database , 2004, Nucleic Acids Res..
[50] G. Karpen,et al. Position-effect variegation and the new biology of heterochromatin. , 1994, Current opinion in genetics & development.
[51] T. Bestor. Gene silencing as a threat to the success of gene therapy. , 2000, The Journal of clinical investigation.
[52] Thomas R Gingeras,et al. Origin of phenotypes: genes and transcripts. , 2007, Genome research.
[53] Hans Martin,et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease , 2010, Nature Medicine.
[54] B. Wakimoto,et al. Heterochromatin and gene expression in Drosophila. , 1995, Annual review of genetics.
[55] Knut Reinert,et al. Integration Preferences of Wildtype AAV-2 for Consensus Rep-Binding Sites at Numerous Loci in the Human Genome , 2010, PLoS pathogens.
[56] H. Ogino,et al. Highly efficient transgenesis in Xenopus tropicalis using I-SceI meganuclease , 2006, Mechanisms of Development.
[57] E. Whitelaw,et al. The vagaries of variegating transgenes. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[58] F. Bushman,et al. Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.
[59] D. Kioussis,et al. Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. , 1997, Current opinion in genetics & development.
[60] J. Orange,et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.
[61] Paul Shinn,et al. HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.
[62] Michel Sadelain,et al. Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells , 2011, Nature Biotechnology.
[63] S. Kattman,et al. Site-specific integration of adeno-associated virus involves partial duplication of the target locus , 2009, Proceedings of the National Academy of Sciences.
[64] M. Sadelain,et al. Reconstructing blood from induced pluripotent stem cells , 2010, F1000 medicine reports.
[65] D. Persons,et al. Solving the problem of γ-retroviral vectors containing long terminal repeats. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[66] Jérôme Larghero,et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.
[67] Christof von Kalle,et al. and insertional genotoxicity Cell culture assays reveal the importance of retroviral vector design for , 2006 .
[68] Frederic D Bushman,et al. Integration target site selection by a resurrected human endogenous retrovirus. , 2009, Genes & development.
[69] F. Campagne,et al. Characterization of the Mouse Adeno-Associated Virus AAVS1 Ortholog , 2004, Journal of Virology.
[70] D. McDermott,et al. CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection. , 2006, Trends in immunology.
[71] P. Gregory,et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.
[72] Frederic D. Bushman,et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. , 2010, The New England journal of medicine.
[73] Jens Boch,et al. TALEs of genome targeting , 2011, Nature Biotechnology.
[74] Yang Du,et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.
[75] Philippe Dessen,et al. Atlas of Genetics and Cytogenetics in Oncology and Haematology, an Interactive Database , 2000, Nucleic Acids Res..
[76] H. Drew,et al. Increased complexity of wild-type adeno-associated virus-chromosomal junctions as determined by analysis of unselected cellular genomes. , 2007, The Journal of general virology.
[77] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[78] A. Smit. Interspersed repeats and other mementos of transposable elements in mammalian genomes. , 1999, Current opinion in genetics & development.
[79] T. Flotte,et al. Latent Adeno-Associated Virus Infection Elicits Humoral but Not Cell-Mediated Immune Responses in a Nonhuman Primate Model , 1999, Journal of Virology.
[80] M. Sadelain,et al. The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[81] C. von Kalle,et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. , 2005, Blood.
[82] Margherita Neri,et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer , 2011, Nature Methods.
[83] J. Ellis. Silencing and variegation of gammaretrovirus and lentivirus vectors. , 2005, Human gene therapy.
[84] P. Fraser. Transcriptional control thrown for a loop. , 2006, Current opinion in genetics & development.
[85] Frederic D Bushman,et al. Methods for integration site distribution analyses in animal cell genomes. , 2009, Methods.
[86] Chris Sander,et al. CancerGenes: a gene selection resource for cancer genome projects , 2006, Nucleic Acids Res..